EUCAST ciprofloxacin area of technical uncertainty in Escherichia coli and Klebsiella pneumoniae using BD Phoenix™ and VITEK® 2 automated susceptibility systems

T. J. Harryvan; E. Schaftenaar; B. T. Franssens; D. C. Melles; R. J. Rentenaar

doi:10.1093/jac/dkae245

EUCAST ciprofloxacin area of technical uncertainty in Escherichia coli and Klebsiella pneumoniae using BD Phoenix™ and VITEK® 2 automated susceptibility systems

T. J. Harryvan, E. Schaftenaar, B. T. Franssens, D. C. Melles, R. J. Rentenaar

Research output: Contribution to journal › Article › Academic › peer-review

4 Downloads (Pure)

Original language	English
Pages (from-to)	2718-2719
Number of pages	2
Journal	The Journal of antimicrobial chemotherapy
Volume	79
Issue number	10
DOIs	https://doi.org/10.1093/jac/dkae245
Publication status	Published - 1 Oct 2024

Access to Document

10.1093/jac/dkae245Licence: CC BY-NC

dkae245Final published version, 290 KBLicence: CC BY-NC

Cite this

@article{68a1976fbaf54d6fab87ed421850b651,

title = "EUCAST ciprofloxacin area of technical uncertainty in Escherichia coli and Klebsiella pneumoniae using BD Phoenix{\texttrademark} and VITEK{\textregistered} 2 automated susceptibility systems",

author = "Harryvan, {T. J.} and E. Schaftenaar and Franssens, {B. T.} and Melles, {D. C.} and Rentenaar, {R. J.}",

year = "2024",

month = oct,

day = "1",

doi = "10.1093/jac/dkae245",

language = "English",

volume = "79",

pages = "2718--2719",

journal = "The Journal of antimicrobial chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "10",

}

EUCAST ciprofloxacin area of technical uncertainty in Escherichia coli and Klebsiella pneumoniae using BD Phoenix™ and VITEK® 2 automated susceptibility systems. / Harryvan, T. J.; Schaftenaar, E.; Franssens, B. T. et al.
In: The Journal of antimicrobial chemotherapy, Vol. 79, No. 10, 01.10.2024, p. 2718-2719.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - EUCAST ciprofloxacin area of technical uncertainty in Escherichia coli and Klebsiella pneumoniae using BD Phoenix™ and VITEK® 2 automated susceptibility systems

AU - Harryvan, T. J.

AU - Schaftenaar, E.

AU - Franssens, B. T.

AU - Melles, D. C.

AU - Rentenaar, R. J.

PY - 2024/10/1

Y1 - 2024/10/1

UR - http://www.scopus.com/inward/record.url?scp=85205525751&partnerID=8YFLogxK

U2 - 10.1093/jac/dkae245

DO - 10.1093/jac/dkae245

M3 - Article

C2 - 39011864

AN - SCOPUS:85205525751

SN - 0305-7453

VL - 79

SP - 2718

EP - 2719

JO - The Journal of antimicrobial chemotherapy

JF - The Journal of antimicrobial chemotherapy

IS - 10

ER -

EUCAST ciprofloxacin area of technical uncertainty in Escherichia coli and Klebsiella pneumoniae using BD Phoenix™ and VITEK® 2 automated susceptibility systems

Access to Document

Other files and links

Cite this